RCEL
AVITA Medical, Inc.Company with tickers: RCEL, AVHHL
CIK
1762303
CUSIP
05380C102
Shares Outstanding
30,776,689
13F Activity (30d)
47 filings
45 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $19,251,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $3,523,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Gross Profit | $15,728,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Expenses | $24,531,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $5,629,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-8,803,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-10,611,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.35 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.35 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |